Strategic Necessity of a Professional GMP Lead Auditor in Israel
The Bottom Line for Global Quality Directors and Supply Chain Managers:
Israel is home to pharmaceutical manufacturers, API suppliers, biotechnology companies and medical device manufacturers serving international markets. Companies sourcing products or services from Israeli suppliers must establish appropriate supplier qualification and oversight controls based on applicable regulatory requirements and risk assessments.
An independent on-site audit can provide valuable evidence of manufacturing controls, quality management system effectiveness, data integrity and GMP compliance. The appropriate audit approach depends on supplier criticality, applicable requirements and the risks associated with outsourced activities.
Working with an independent, Israel-based lead auditor can reduce international travel requirements and simplify audit scheduling, communication with local suppliers, and on-site evidence review. Audit findings are based on the agreed scope, applicable criteria, sampling, and objective evidence. An independent audit supports supplier oversight but does not guarantee regulatory compliance or establish that a supplier is operating under a continuous state of control.
Israel is home to pharmaceutical and API manufacturers, biotechnology operations, and medical device companies serving international markets. A pharmaceutical GMP supplier audit may evaluate quality management systems, manufacturing processes, facilities, equipment, validation, data integrity, and supplier controls. Medical device and software supplier audits require assessment against the applicable quality and regulatory requirements, such as ISO 13485 and relevant software lifecycle controls where appropriate. An independent supplier audit is distinct from an inspection conducted by a regulatory authority.
Why Conduct GMP Audits in Israel
Audits and regulatory inspections serve different purposes. In the pharmaceutical sector, internal audits and supplier assessments help organizations evaluate quality management systems, manufacturing controls, outsourced activities and conformity with defined requirements.
The appropriate supplier evaluation and monitoring methods should be determined according to applicable regulatory requirements, supplier criticality and documented risks. An independent on-site GMP audit can provide valuable evidence of supplier capabilities and compliance, but it is not universally mandatory for every supplier.
Professional GMP Auditors examine the data trail to determine if company policies are followed and implemented properly.
The Six Pillars of GMP Control
A pharmaceutical GMP supplier audit may assess several key areas of manufacturing and quality-system control. The specific areas selected for examination depend on the facility’s activities, applicable GMP requirements, audit objectives and identified risks.
The following six areas illustrate common subjects evaluated during a pharmaceutical GMP audit:
- Facility — Environmental controls and cleanroom integrity
- Equipment — Validation, calibration, and maintenance
- Raw Materials — Supplier qualification and testing
- Operation — Adherence to validated manufacturing protocols
- Training — Personnel competency and GxP awareness
- Finished Products — Quality control and batch release standards
The Vital Role of QMS and Auditing
Auditing has become a primary key to success in the pharmaceutical industry. Regulatory agencies such as the Israeli Ministry of Health (IMOH), FDA, and EMA ensure that only safe and effective products reach the public. Pharmaceutical manufacturers use audits as a mechanism to verify that control systems are operating under a continuous state of control. A professional audit can detect potential problems to permit timely correction and establish a high range of confidence for executive management.
Key Documents for Planning and Recording a GMP Supplier Audit
An effective supplier GMP audit requires appropriate planning, defined audit criteria and documented objective evidence. Depending on the audit scope and the commissioning client’s procedures, the following documents may be used to plan, conduct and record the assessment.
| Document Type | Strategic Purpose |
|---|---|
| Risk Assessment | Identifies relevant risk factors that challenge an organizational area and considers their significance. |
| Scope Statement | Identifies the specific activities, project justification, deliverables, and success criteria covered. |
| Audit Program | A document containing the listing of audit procedures and the specific objectives of the audit. |
| Audit Procedures | The specific tasks the auditor follows to gather, analyze, and document evidence during the audit. |
| Work-papers | Detailed documentation from interviews and testing conducted to complete the audit program. |
Objectives of the Lead Auditor During Inspection
The lead auditor evaluates objective evidence to determine whether the audited activities conform to the agreed audit criteria. The assessment may identify nonconformities, weaknesses in quality-system implementation and opportunities for improvement.
Audit findings and conclusions are based on the evidence reviewed within the defined audit scope. An independent supplier audit does not replace a regulatory inspection or guarantee future regulatory compliance.
This includes evaluating supplier capabilities before establishing a contractual relationship and verifying that the internal quality system continues to meet evolving global standards.
Types of GMP Audits and Inspections
Understanding the distinction between audit types is essential for maintaining a compliant supply chain.
- First-Party Audit (Internal Audit): Conducted by or on behalf of an organization to evaluate its own processes and quality management system against established audit criteria.
- Second-Party Audit (Supplier Audit): Conducted by a customer or an auditor acting on the customer’s behalf to assess a supplier, contractor or outsourced activity against agreed quality and regulatory requirements.
- Third-Party Audit: Conducted by an independent external auditing organization, for example as part of a recognized management system certification process.
- Regulatory Inspection: Conducted by an authorized regulatory authority, such as the FDA or Israeli Ministry of Health, to assess compliance with applicable legal and regulatory requirements. Regulatory inspections are distinct from customer-commissioned supplier audits and third-party certification audits
Standard GMP and Quality Auditing Procedure
A supplier GMP audit typically follows a structured process adapted to the audit objectives, facility activities and applicable requirements.
The process generally includes:
- Audit Scope and Criteria: Define the audit objectives, applicable standards, regulatory requirements, facility activities and reporting expectations.
- Audit Planning: Establish the audit agenda, sampling approach, required documentation and logistics.
- Opening Meeting: Confirm the scope, schedule, communication arrangements and relevant site requirements.
- On-Site Assessment: Review facilities, operations, quality systems, records and personnel practices, as applicable.
- Evaluation of Evidence: Assess conformity against the defined audit criteria and document relevant observations.
- Closing Meeting: Present the audit findings and clarify the subsequent reporting process.
- Audit Report: Issue a documented report containing the scope, methodology, evidence-based findings and conclusions.
- Corrective Action Follow-Up: Where included in the engagement, review supplier responses, proposed CAPA and evidence of implementation or effectiveness.
The audited organization remains responsible for investigating nonconformities and implementing appropriate corrective actions.
Frequently Asked Questions
Is a local auditor better than a foreign team for Israeli inspections?
An Israel-based auditor can offer practical advantages, including local availability, Hebrew-language communication, familiarity with Israeli manufacturing environments and reduced international travel costs. However, auditor selection should primarily depend on relevant technical competence, independence, experience and the specific audit scope. A local auditor is not automatically more qualified than an international audit team.
What happens if a major non-conformity is found?
A major nonconformity is documented and communicated according to the agreed audit procedure and finding classification criteria. The audited organization is generally responsible for investigating the finding, determining its root cause and proposing appropriate corrective actions. The commissioning company evaluates the supplier’s response and determines the necessary follow-up based on risk, applicable requirements and quality agreements.
Can you audit digital health and software suppliers?
Yes. Independent audits of digital health and Software as a Medical Device (SaMD) suppliers may evaluate quality management systems, software lifecycle processes, design controls, software verification and validation, risk management and applicable cybersecurity requirements. Depending on the product and audit scope, relevant criteria may include ISO 13485, IEC 62304, ISO 14971 and applicable regulatory requirements.
Can an independent GMP auditor in Israel audit a pharmaceutical supplier on behalf of an international company?
Yes. An independent Israel-based GMP auditor can conduct an on-site assessment of a pharmaceutical supplier, API manufacturer or contract manufacturing organization on behalf of an international client, subject to an agreed audit scope and access to the facility.
The audit may address applicable GMP requirements, quality management systems, manufacturing controls, validation, data integrity and supplier quality processes. The findings are documented in an evidence-based audit report to support the client’s supplier qualification and oversight decisions.
Contact Eran Yona for Lead Auditor Services in Israel
Protect your brand and ensure your suppliers meet global quality standards.
Reach out today for professional QMS and GMP auditing services tailored to the Bio-Med industry.
Request an Independent GMP Audit in Israel
- Email [email protected]
- Phone +(972) 51-5001353
- LinkedIn linkedin.com/in/eranyona
- Website www.eranyona.com





